Gevo, Inc. (GEVO) Balance Sheet

The simultaneous collapse in PPE net (from $361.5M in 2026Q1 to $241.5M in 2026Q2) and retained earnings (from -$855.6M to -$1.0B) strongly suggests a large non-cash impairment charge in 2026Q2, consistent with the prior income statement finding of a -$176.9M net loss. This pattern mirrors the prior statement's identification of an anomalous quarter, and on the balance sheet it manifests as real equity destruction rather than a mere accounting reclassification. Investors should monitor whether further write-downs follow or whether this represents a one-time recalibration of asset carrying values post-acquisition.

Debt itself has been broadly flat near $170M since 2025Q1, reflecting what appears to be a strategic decision to lever up after the transformational acquisition rather than necessity-driven distress borrowing. However, the equity denominator shrinking below $300M means that even modest future borrowing or continued losses could push leverage into a range that constrains refinancing options. Given the prior cash flow finding of sustained negative FCF, the fixed debt service on $170.7M appears to be a growing strain on an already cash-constrained balance sheet.

At $58.1M in cash against a current ratio of 2.70, Gevo still has near-term coverage, but the trajectory is what concerns us — cash has fallen roughly 79% over ten quarters while operating losses and capex persist, per the prior cash flow analysis. If the ~$10M quarterly capex and operating burn continue as observed, the current cash balance suggests a runway measured in low single-digit quarters absent a financing event. The appearing deferred revenue line at $3.3M in 2026Q2 offers negligible offset and may indicate early contract prepayments rather than a material cash source.